Add BrightSurf on Google Email

Bacterial link in celiac disease

Scientists have discovered a molecular foundation for bacterial exposure as a potential environmental factor in coeliac disease development. Receptors from immune T cells can recognize protein fragments from certain bacteria that mimic gluten, leading to aberrant recognition and health problems.

SourceMonash University·JournalNature Structural & Molecular Biology·DateJan 8, 2020

A mother's bugs

Research shows that maternal microbiota provides immunity to newborns against E. coli, a disease-causing microbe. The study reveals that antibodies are passed on to offspring through milk and the placenta, offering protection beyond just breastfeeding.

SourceHarvard Medical School·JournalNature·DateJan 8, 2020

New technique to identify a common cause to TMA diseases for which there is a treatment

Researchers develop a new technique to detect activated complement pathway in patients with thrombotic microangiopathies (TMA), allowing clinicians to determine potential use of existing treatment for other diseases. The technique could lead to improved diagnosis and treatment of secondary TMAs, such as pre-eclampsia and HELLP syndrome.

SourceJosep Carreras Leukaemia Research Institute·JournalClinical Journal of the American Society of Nephrology·DateNov 8, 2019

New treatment may reverse celiac disease

A new phase 2 clinical trial shows that technology can induce immune tolerance to gluten in individuals with celiac disease, reducing inflammation and protecting the small intestine. The treatment, called CNP-101, is a biodegradable nanoparticle containing gluten that convinces the immune system it's safe.

CNIO and University of Wurzburg solve 3D structure of 'nanomachine' that makes tuberculosis virulent

Researchers at CNIO and the University of Würzburg have solved the 3D structure of the T7SS nanomachine used by Mycobacterium tuberculosis to evade the immune system. This finding provides crucial information for developing new therapeutic strategies against tuberculosis, a disease that kills over 1.6 million people worldwide each year.

Parkinson's disease is also present in the blood

Researchers from Aarhus University discovered that Parkinson's patients have an immune imbalance in their blood, affecting the regulation of immune cells and anti-inflammatory molecules. This finding advocates for immune modulation as a potential alternative treatment for the disease.

SourceAarhus University·JournalMovement Disorders·DateOct 3, 2019

Using the immune system as a defence against cancer

Researchers at King's College London have discovered that β-Galactoside-Binding Protein (βGBP) can selectively target and kill cancer cells while stimulating the immune system to provide long-term protection against cancer recurrence. The study presents a promising new strategy for treating aggressive forms of cancer.

SourceKing's College London·JournalBritish Journal of Cancer·DateSep 26, 2019

Deciphering pancreatic cancer's invade and evade tactics

Two known gene mutations, KRAS and TP53, induce pathways that enhance pancreatic cancer's ability to invade tissues and evade the immune system. Mutations in these genes are closely linked to pancreatic ductal adenocarcinoma, a type of pancreatic cancer with a low five-year survival rate.

SourceHokkaido University·JournalProceedings of the National Academy of Sciences·DateAug 5, 2019

Fear of predators increases risk of illness

Research at Lund University reveals that prey animals with a weaker immune system have an increased risk of illness due to chronic stress from predator presence. The study found that bold individuals with a greater need for defense exhibit a better immune response.

SourceLund University·JournalJournal of Animal Ecology·DateJul 9, 2019

Old protein, new tricks: UMD connects a protein to antibody immunity for the first time

Scientists have discovered a newly found function of the US11 protein that impairs antibody immunity, allowing human cytomegalovirus (HCMV) to evade white blood cells and potentially leading to birth defects and immune system dysfunction. This breakthrough has significant therapeutic prospects for treating autoimmune diseases like lupus.

SourceUniversity of Maryland·JournalNature Communications·DateJul 9, 2019

Women caught in a pickle by their own immune systems

Researchers at Arizona State University have developed a new hypothesis to explain the phenomenon of women being more prone to autoimmune diseases like multiple sclerosis and lupus. The Pregnancy Compensation Hypothesis suggests that women's immune systems evolved to facilitate survival during pregnancy, leading to heightened immune su...

SourceArizona State University·JournalTrends in Genetics·DateJun 11, 2019

Filming how our immune system kills bacteria

Researchers use atomic force microscopy to track the formation of deadly holes in bacterial surfaces, discovering a bottleneck that prevents harm to human cells. The study provides insight into how the immune system kills bacteria and may guide the development of new therapies harnessing the immune system against bacterial infections.

SourceUniversity College London·JournalNature Communications·DateMay 6, 2019

Lifetime flu vaccine?

A new vaccine approach could protect against pandemic flu by teaching the immune system to recognize the shared 'cone' portion of the flu virus, rather than just the seasonal 'scoop'. Researchers have shown early promising results in lab animals.

SourceStanford University·JournalProceedings of the National Academy of Sciences·DateApr 26, 2019

'Superbugs' found on many hospital patients' hands and what they touch most often

A new study found that nearly a third of hospital room surfaces had antibiotic-resistant bacteria on them, suggesting rapid transmission from patients to their environment. The research team suggests expanding hand hygiene efforts to include patients, as healthcare workers' hands remain the primary mode of microbe transmission.

SourceMichigan Medicine - University of Michigan·JournalClinical Infectious Diseases·DateApr 13, 2019

Aspirin to fight an expensive global killer infection

Researchers at the Centenary Institute discovered that the tuberculosis bacterium hijacks platelets from the body's blood clotting system to weaken immune systems. Using anti-platelet drugs like aspirin, they were able to prevent hijacking and allow the body to control infection better.

SourceCentenary Institute·JournalThe Journal of Infectious Diseases·DateMar 25, 2019